Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07042152 · ClinicalTrials.gov registry record · NA
Wearable Device and Behavioral Support for Enhancing Arm Use After Stroke
A NA study of Chronic Stroke Patients, sponsored by University of California, Irvine.
- Recruiting
- Registry status
- NA
- Development phase
- 32
- Enrollment target
- 1
- Study location
NCT07042152: Recruiting NA study of Chronic Stroke Patients, sponsored by University of California, Irvine.
NCT07042152 is a NA study of Chronic Stroke Patients that is actively recruiting participants, run by University of California, Irvine. The registered enrollment target is 32 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07042152, a NA study of Chronic Stroke Patients, is actively recruiting participants, sponsored by University of California, Irvine.
- RECRUITING
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to determine the effectiveness of behavioral support and feedback from a wearable device that senses arm movement in improving upper extremity function in a pilot, randomized controlled trial with chronic stroke patients
Primary Outcome
The amount of variability for the impaired upper extremity will be quantified by the variety of movements performed.
Conditions Studied
Interventions
- OTHER Smartwatch App for Movement Variability
- OTHER Smartwatch App for Active Time
- BEHAVIORAL Motivational Interviewing (Within Subjects)
Study Locations (1)
California
- University of California Irvine - Irvine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2025-08-20 |
| Est. Completion | 2026-01-29 |
| Phase | NA |
What NCT07042152 shows while recruiting
NCT07042152 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Chronic Stroke Patients appearing as the primary indexed condition, and to 3 interventions - of which Smartwatch App for Movement Variability is the first listed.
NCT07042152 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT07042152 about?
NCT07042152 is a clinical study titled "Wearable Device and Behavioral Support for Enhancing Arm Use After Stroke". The goal of this study is to determine the effectiveness of behavioral support and feedback from a wearable device that senses arm movement in improving upper extremity function in a pilot, randomized controlled trial with chronic stroke patients
What is the current status of trial NCT07042152?
This trial is currently recruiting. It is a NA study. The enrollment target is 32 participants. The study started on 2025-08-20. Estimated completion is 2026-01-29.
What conditions does trial NCT07042152 study?
This clinical trial studies the following conditions: Chronic Stroke Patients.
What interventions are being tested in trial NCT07042152?
The interventions under investigation include: Smartwatch App for Movement Variability (OTHER), Smartwatch App for Active Time (OTHER), Motivational Interviewing (Within Subjects) (BEHAVIORAL).
Who is sponsoring clinical trial NCT07042152?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07042152 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Stroke Patients
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07042152's enrollment target sits among peer trials
32 1578th of 2000 higher than 409 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI